Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Universal Ibogaine Inc V.IBO

Alternate Symbol(s):  IBOGF

Universal Ibogaine Inc. is a Canada-based life sciences company. The Company is transforming addiction treatment using medicalized ibogaine through a planned Canadian clinical trial focused on opioid use disorders. The Company is engaged in developing a holistic addiction treatment protocol at its Kelburn Recovery Center (located near Winnipeg, Manitoba), which paired with the planned ibogaine detox protocol, is intended to treat addiction and improve the lives of individuals and families affected by addiction. Ibogaine is a naturally occurring molecule derived from the root bark of the iboga tree and other plants. It is a potent and serious medical psychedelic which has addiction interrupting properties. Ibogaine targets multiple receptors across multiple sites in the brain and metabolizes into noribogaine, a serotonin re-uptake inhibitor that remains in the body for 1-4 months, associated with elimination of addictive cravings.


TSXV:IBO - Post by User

Universal Ibogaine Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(321)
•••
Post by yukon_goldon Sep 27, 2022 8:13pm
227 Views
Post# 34990883

Universal Ibogaine is Featured in a New Documentary Series

Universal Ibogaine is Featured in a New Documentary Series
image
 

UNIVERSAL IBOGAINE IS FEATURED IN A NEW DOCUMENTARY SERIES

Dear Shareholders, Friends and Investors,

We trust this note finds you well in these interesting times we live in. We are happy to share a bit of good news today, Universal Ibogaine has been featured in a new documentary series co-produced by Kyle Buller and Joe Moore in conjunction with ALTRD.TV. Kyle and Joe are the hosts of a well respected podcast series Psychedelics Today.

Read the full news release here.

The documentary series provides a deep dive into the history and future potential of a number of psychoactive compounds. Episode 1 covers the iboga plant from which ibogaine is derived.

Watch the first episode here.

We are very pleased with the media coverage, we hope this documentary series can continue to create education and awareness about the incredible healing power of ibogaine.

Please stay tuned, more news to come.

Nick Karos CEO

 

For any questions, please contact us through info@universalibogaine.com
 

Please let us know if you have have any questions or feedback, we love hearing from our community, we could not do this without you!
Profile Image Universal Ibogaine Info@UniversalIbogaine.com 1 (855) IBOGAINE - (426-4246) UniversalIbogaine.com
 
 
Facebook Twitter LinkedIn YouTube

Universal Ibogaine Inc. 595 Howe Street Suite 303 Vancouver, British Columbia V6C2T5 Canada 1 (855) 426-4246

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities